看这个，好象还没有END；

72

•  

   
•  

   

•  
•  

 

Vandana Singh

Fri, February 24, 2023 at 9:03 AM PST

 

 

In this article:

•  

   
•  

   

• PFE

  -1.30%

  Watchlist

  Watchlist

  Recommendation Rating

  Buy

   
• BNTX

  -0.80%

   

 

 

 

 

 

 

• Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have submitted an FDA supplemental marketing application for approval of omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as a primary series and booster dose(s) for 12 years and older.

• In January, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to harmonize the composition of COVID-19 vaccines across booster and primary series doses.

• If this supplemental application is approved, people 12 or older can receive the companies' omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for their primary series rather than completing their primary series with the original before having access to the bivalent vaccine.